BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34838219)

  • 1. COVID-19 vaccine intentions in Australia.
    Pickles K; Copp T; Dodd RH; Cvejic E; Seale H; Steffens MS; Meyerowitz-Katz G; Bonner C; McCaffery K
    Lancet Infect Dis; 2021 Dec; 21(12):1627-1628. PubMed ID: 34838219
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 vaccine intentions in Australia.
    Edwards B; Biddle N; Gray M; Sollis K
    Lancet Infect Dis; 2021 Dec; 21(12):1628-1629. PubMed ID: 34838220
    [No Abstract]   [Full Text] [Related]  

  • 3. Examining Australian public perceptions and behaviors towards a future COVID-19 vaccine.
    Seale H; Heywood AE; Leask J; Sheel M; Durrheim DN; Bolsewicz K; Kaur R
    BMC Infect Dis; 2021 Jan; 21(1):120. PubMed ID: 33509104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Australia: Epidemiology Report 38 Reporting period ending 28 March 2021.
    COVID-19 National Incident Room Surveillance Team
    Commun Dis Intell (2018); 2021 Apr; 45():. PubMed ID: 33845717
    [No Abstract]   [Full Text] [Related]  

  • 5. Willingness to vaccinate against COVID-19 in Australia.
    Dodd RH; Cvejic E; Bonner C; Pickles K; McCaffery KJ;
    Lancet Infect Dis; 2021 Mar; 21(3):318-319. PubMed ID: 32619436
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19 Australia: Epidemiology Report 41: Reporting period ending 9 May 2021.
    COVID-19 National Incident Room Surveillance Team
    Commun Dis Intell (2018); 2021 May; 45():. PubMed ID: 34074235
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19 Australia: Epidemiology Report 40: Reporting period ending 25 April 2021.
    COVID-19 National Incident Room Surveillance Team
    Commun Dis Intell (2018); 2021 May; 45():. PubMed ID: 34074231
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID-19 vaccine access in Africa: Global distribution, vaccine platforms, and challenges ahead.
    Massinga Loembé M; Nkengasong JN
    Immunity; 2021 Jul; 54(7):1353-1362. PubMed ID: 34260880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
    Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ
    Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.
    McBryde ES; Meehan MT; Caldwell JM; Adekunle AI; Ogunlade ST; Kuddus MA; Ragonnet R; Jayasundara P; Trauer JM; Cope RC
    Med J Aust; 2021 Nov; 215(9):427-432. PubMed ID: 34477236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual preferences for COVID-19 vaccination in China.
    Leng A; Maitland E; Wang S; Nicholas S; Liu R; Wang J
    Vaccine; 2021 Jan; 39(2):247-254. PubMed ID: 33328140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Ace Up Our Sleeves: The COVID-19 Vaccine Rollout Revealed Our Strengths and Our Neglected Public Health Infrastructure.
    Pierce HH
    J Public Health Manag Pract; 2021 May-Jun 01; 27(3):223-225. PubMed ID: 33762537
    [No Abstract]   [Full Text] [Related]  

  • 13. Tracking COVID-19 vaccine hesitancy and logistical challenges: A machine learning approach.
    Dutta S; Kumar A; Dutta M; Walsh C
    PLoS One; 2021; 16(6):e0252332. PubMed ID: 34077467
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19 vaccinations: The unknowns, challenges, and hopes.
    Mohamed K; Rzymski P; Islam MS; Makuku R; Mushtaq A; Khan A; Ivanovska M; Makka SA; Hashem F; Marquez L; Cseprekal O; Filgueiras IS; Fonseca DLM; Mickael E; Ling I; Arero AG; Cuschieri S; Minakova K; Rodríguez-Román E; Abarikwu SO; Faten AB; Grancini G; Cabral-Marques O; Rezaei N
    J Med Virol; 2022 Apr; 94(4):1336-1349. PubMed ID: 34845731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The correlation between conspiracy mentality and vaccine intentions is moderated by social events: Evidence from longitudinal data during COVID-19 pandemic in the UK.
    Adinugroho I; Stafford T; Bentall RP
    Vaccine; 2024 Jun; 42(16):3607-3614. PubMed ID: 38704262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 Vaccine Perceptions Among Patients With Chronic Disease in a Large Gastroenterology and Hepatology Practice.
    Serper M; Reddy KR; Bewtra M; Ahmad N; Mehta SJ
    Am J Gastroenterol; 2021 Jun; 116(6):1345-1349. PubMed ID: 33878043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How COVID vaccines shaped 2021 in eight powerful charts.
    Mallapaty S; Callaway E; Kozlov M; Ledford H; Pickrell J; Van Noorden R
    Nature; 2021 Dec; 600(7890):580-583. PubMed ID: 34916666
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19 vaccination in Israel.
    Muhsen K; Cohen D
    Clin Microbiol Infect; 2021 Nov; 27(11):1570-1574. PubMed ID: 34384875
    [No Abstract]   [Full Text] [Related]  

  • 19. Broad cross-national public support for accelerated COVID-19 vaccine trial designs.
    Broockman D; Kalla J; Guerrero A; Budolfson M; Eyal N; Jewell NP; Magalhaes M; Sekhon JS
    Vaccine; 2021 Jan; 39(2):309-316. PubMed ID: 33334616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opting Out of Vaccines for Your Child.
    Rosenthal CM; Thompson LA
    JAMA Pediatr; 2020 Sep; 174(9):916. PubMed ID: 32716493
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.